Infectious Diseases and Antimicrobial Resistance (ISIDAR-26)

This track will explore the molecular and genetic mechanisms underlying antimicrobial resistance in various pathogens. Understanding these mechanisms is crucial for developing effective therapeutic strategies and interventions.

This session will focus on the discovery and development of novel antimicrobial agents and therapeutic approaches. Emphasis will be placed on innovative strategies to combat resistant infections and improve clinical outcomes.

This track will address the latest advancements in surveillance techniques and diagnostic methods for infectious diseases. Effective detection is essential for timely intervention and control of outbreaks.

This session will examine evidence-based practices for infection prevention and control in healthcare settings. Participants will discuss the implementation of successful strategies to reduce the transmission of infectious diseases.

This track will highlight the importance of antimicrobial stewardship programs in optimizing the use of antimicrobials. Discussions will focus on strategies to minimize resistance and improve patient outcomes.

This session will investigate the impact of infectious diseases on clinical outcomes and patient quality of life. Research findings will be presented to illustrate the importance of effective management and treatment.

This track will emphasize the role of multidisciplinary teams in addressing the complexities of infectious disease management. Collaboration among healthcare professionals is vital for comprehensive patient care.

This session will focus on the formulation and implementation of policies aimed at controlling infectious diseases and antimicrobial resistance. Participants will discuss challenges and successes in policy development.

This track will provide a platform for discussing global trends and challenges in infectious disease management. Participants will share insights on international collaboration and responses to emerging threats.

This session will explore the emergence of new infectious diseases and their implications for public health. The focus will be on preparedness, response strategies, and lessons learned from recent outbreaks.

This track will showcase cutting-edge research on the pathogenesis of infectious diseases. Understanding the interactions between pathogens and host responses is essential for developing targeted therapies.